Retrotransposon methylation profiles and survival in Black women with high-grade serous ovarian carcinoma

Abstract Introduction Retrotransposons (REs) constitute nearly half of the genome and include long terminal repeat (LTR) elements, Long INterspersed Elements (LINE), and Short INterspersed Elements (SINE). REs are typically silenced in somatic tissues via DNA methylation but can be reactivated throu...

Full description

Saved in:
Bibliographic Details
Main Authors: Christelle Colin-Leitzinger, Katherine A. Lawson-Michod, Courtney E. Johnson, Irma M. Vlasac, Sean Yoder, Tania Mesa, Dana Roeber, Chad Huff, Michelle A. T. Hildebrandt, Kristin Haller, Anthony J. Alberg, Elisa V. Bandera, Melissa Bondy, Michele L. Cote, Theresa Hastert, Edward S. Peters, Paul D. Terry, Andrew B. Lawson, Andrew Berchuck, Brooke L. Fridley, Jing-Yi Chern, Jennifer A. Doherty, Jeffrey R. Marks, Joellen M. Schildkraut, Brock C. Christensen, Lucas A. Salas, Lauren C. Peres
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Clinical Epigenetics
Online Access:https://doi.org/10.1186/s13148-025-01942-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849235127120429056
author Christelle Colin-Leitzinger
Katherine A. Lawson-Michod
Courtney E. Johnson
Irma M. Vlasac
Sean Yoder
Tania Mesa
Dana Roeber
Chad Huff
Michelle A. T. Hildebrandt
Kristin Haller
Anthony J. Alberg
Elisa V. Bandera
Melissa Bondy
Michele L. Cote
Theresa Hastert
Edward S. Peters
Paul D. Terry
Andrew B. Lawson
Andrew Berchuck
Brooke L. Fridley
Jing-Yi Chern
Jennifer A. Doherty
Jeffrey R. Marks
Joellen M. Schildkraut
Brock C. Christensen
Lucas A. Salas
Lauren C. Peres
author_facet Christelle Colin-Leitzinger
Katherine A. Lawson-Michod
Courtney E. Johnson
Irma M. Vlasac
Sean Yoder
Tania Mesa
Dana Roeber
Chad Huff
Michelle A. T. Hildebrandt
Kristin Haller
Anthony J. Alberg
Elisa V. Bandera
Melissa Bondy
Michele L. Cote
Theresa Hastert
Edward S. Peters
Paul D. Terry
Andrew B. Lawson
Andrew Berchuck
Brooke L. Fridley
Jing-Yi Chern
Jennifer A. Doherty
Jeffrey R. Marks
Joellen M. Schildkraut
Brock C. Christensen
Lucas A. Salas
Lauren C. Peres
author_sort Christelle Colin-Leitzinger
collection DOAJ
description Abstract Introduction Retrotransposons (REs) constitute nearly half of the genome and include long terminal repeat (LTR) elements, Long INterspersed Elements (LINE), and Short INterspersed Elements (SINE). REs are typically silenced in somatic tissues via DNA methylation but can be reactivated through DNA hypomethylation, potentially impacting gene regulation. Here, we investigate genome-scale profiles of RE methylation in high-grade serous ovarian carcinoma (HGSOC) and associations with survival among Black women. Methods Methylation levels of LTR, LINE-1, and Alu (type of SINE) in 200 HGSOC tumors were predicted using a random forest approach and clustered using multiple consensus algorithms. Associations between RE methylation clusters and survival were evaluated using Cox proportional hazard regression, adjusting for age, stage, and debulking status. We performed sensitivity analyses restricted to women with late-stage disease and with adjustment for BRCA1/BRCA2 mutations. Results Two RE methylation clusters were identified. Cluster 1 exhibited a more hypomethylated RE profile (“Active”), while Cluster 2 was more hypermethylated (“Repressed”). No statistically significant differences in patient or clinical characteristics were observed between clusters. Compared to the Active Cluster, the Repressed Cluster was associated with an increased risk of mortality (HR = 2.41; 95% CI 1.04–5.59) and had a lower proportion of T cells. This association was consistent in sensitivity analyses. Conclusion A more hypermethylated RE profile was linked to worse survival among Black women with HGSOC, highlighting the potential of RE methylation as a prognostic biomarker. Further research is needed to understand the underlying biological mechanisms and their implications in ovarian cancer biology and treatment.
format Article
id doaj-art-393df9a892b449a28095b8f043ee9191
institution Kabale University
issn 1868-7083
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Clinical Epigenetics
spelling doaj-art-393df9a892b449a28095b8f043ee91912025-08-20T04:02:54ZengBMCClinical Epigenetics1868-70832025-07-0117111110.1186/s13148-025-01942-9Retrotransposon methylation profiles and survival in Black women with high-grade serous ovarian carcinomaChristelle Colin-Leitzinger0Katherine A. Lawson-Michod1Courtney E. Johnson2Irma M. Vlasac3Sean Yoder4Tania Mesa5Dana Roeber6Chad Huff7Michelle A. T. Hildebrandt8Kristin Haller9Anthony J. Alberg10Elisa V. Bandera11Melissa Bondy12Michele L. Cote13Theresa Hastert14Edward S. Peters15Paul D. Terry16Andrew B. Lawson17Andrew Berchuck18Brooke L. Fridley19Jing-Yi Chern20Jennifer A. Doherty21Jeffrey R. Marks22Joellen M. Schildkraut23Brock C. Christensen24Lucas A. Salas25Lauren C. Peres26Moffitt Cancer CenterPopulation Health Sciences, Huntsman Cancer Institute, University of UtahRollins School of Public Health, Emory UniversityGeisel School of Medicine, Dartmouth CollegeMoffitt Cancer CenterMoffitt Cancer CenterMoffitt Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterRollins School of Public Health, Emory UniversityUniversity of South Carolina Arnold School of Public HealthRutgers Cancer InstituteStanford University School of MedicineMelvin and Bren Simon Comprehensive Cancer Center, Indiana UniversityKarmanos Cancer Institute, Wayne State UniversityUniversity of Nebraska Medical CenterUniversity of Tennessee Medical CenterMedical University of South CarolinaDuke University School of MedicineChildren’s Mercy HospitalMoffitt Cancer CenterPopulation Health Sciences, Huntsman Cancer Institute, University of UtahDuke University School of MedicineRollins School of Public Health, Emory UniversityGeisel School of Medicine, Dartmouth CollegeGeisel School of Medicine, Dartmouth CollegeMoffitt Cancer CenterAbstract Introduction Retrotransposons (REs) constitute nearly half of the genome and include long terminal repeat (LTR) elements, Long INterspersed Elements (LINE), and Short INterspersed Elements (SINE). REs are typically silenced in somatic tissues via DNA methylation but can be reactivated through DNA hypomethylation, potentially impacting gene regulation. Here, we investigate genome-scale profiles of RE methylation in high-grade serous ovarian carcinoma (HGSOC) and associations with survival among Black women. Methods Methylation levels of LTR, LINE-1, and Alu (type of SINE) in 200 HGSOC tumors were predicted using a random forest approach and clustered using multiple consensus algorithms. Associations between RE methylation clusters and survival were evaluated using Cox proportional hazard regression, adjusting for age, stage, and debulking status. We performed sensitivity analyses restricted to women with late-stage disease and with adjustment for BRCA1/BRCA2 mutations. Results Two RE methylation clusters were identified. Cluster 1 exhibited a more hypomethylated RE profile (“Active”), while Cluster 2 was more hypermethylated (“Repressed”). No statistically significant differences in patient or clinical characteristics were observed between clusters. Compared to the Active Cluster, the Repressed Cluster was associated with an increased risk of mortality (HR = 2.41; 95% CI 1.04–5.59) and had a lower proportion of T cells. This association was consistent in sensitivity analyses. Conclusion A more hypermethylated RE profile was linked to worse survival among Black women with HGSOC, highlighting the potential of RE methylation as a prognostic biomarker. Further research is needed to understand the underlying biological mechanisms and their implications in ovarian cancer biology and treatment.https://doi.org/10.1186/s13148-025-01942-9
spellingShingle Christelle Colin-Leitzinger
Katherine A. Lawson-Michod
Courtney E. Johnson
Irma M. Vlasac
Sean Yoder
Tania Mesa
Dana Roeber
Chad Huff
Michelle A. T. Hildebrandt
Kristin Haller
Anthony J. Alberg
Elisa V. Bandera
Melissa Bondy
Michele L. Cote
Theresa Hastert
Edward S. Peters
Paul D. Terry
Andrew B. Lawson
Andrew Berchuck
Brooke L. Fridley
Jing-Yi Chern
Jennifer A. Doherty
Jeffrey R. Marks
Joellen M. Schildkraut
Brock C. Christensen
Lucas A. Salas
Lauren C. Peres
Retrotransposon methylation profiles and survival in Black women with high-grade serous ovarian carcinoma
Clinical Epigenetics
title Retrotransposon methylation profiles and survival in Black women with high-grade serous ovarian carcinoma
title_full Retrotransposon methylation profiles and survival in Black women with high-grade serous ovarian carcinoma
title_fullStr Retrotransposon methylation profiles and survival in Black women with high-grade serous ovarian carcinoma
title_full_unstemmed Retrotransposon methylation profiles and survival in Black women with high-grade serous ovarian carcinoma
title_short Retrotransposon methylation profiles and survival in Black women with high-grade serous ovarian carcinoma
title_sort retrotransposon methylation profiles and survival in black women with high grade serous ovarian carcinoma
url https://doi.org/10.1186/s13148-025-01942-9
work_keys_str_mv AT christellecolinleitzinger retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT katherinealawsonmichod retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT courtneyejohnson retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT irmamvlasac retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT seanyoder retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT taniamesa retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT danaroeber retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT chadhuff retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT michelleathildebrandt retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT kristinhaller retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT anthonyjalberg retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT elisavbandera retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT melissabondy retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT michelelcote retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT theresahastert retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT edwardspeters retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT pauldterry retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT andrewblawson retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT andrewberchuck retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT brookelfridley retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT jingyichern retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT jenniferadoherty retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT jeffreyrmarks retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT joellenmschildkraut retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT brockcchristensen retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT lucasasalas retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma
AT laurencperes retrotransposonmethylationprofilesandsurvivalinblackwomenwithhighgradeserousovariancarcinoma